NYSE:HCA - HCA Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $153.42
  • Forecasted Upside: 0.01 %
  • Number of Analysts: 19
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 17 Buy Ratings
  • 0 Strong Buy Ratings
$153.40
▼ -0.22 (-0.14%)
1 month | 3 months | 12 months
Get New HCA Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$153.42
▲ +0.01% Upside Potential
This price target is based on 19 analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $153.42, with a high forecast of $180.00 and a low forecast of $100.00. The average price target represents a 0.01% upside from the last price of $153.40.
Buy
The current consensus among 19 investment analysts is to buy stock in HCA Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 17 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/5/2019
  • 0 strong buy ratings
  • 17 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/3/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2019
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/1/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/30/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/28/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/27/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/26/2020

Latest Recommendations

  • 0 strong buy ratings
  • 17 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/11/2020Piper SandlerBoost Price TargetOverweight$149.00 ➝ $163.00High
i
10/27/2020Smith Barney CitigroupBoost Price Target$142.00 ➝ $155.00Medium
i
10/27/2020Piper SandlerBoost Price TargetNeutral$138.00 ➝ $149.00High
i
10/27/2020Raymond JamesBoost Price TargetOutperform$140.00 ➝ $150.00High
i
10/27/2020Credit Suisse GroupBoost Price TargetOutperform$158.00 ➝ $164.00High
i
10/27/2020MizuhoBoost Price TargetBuy$145.00 ➝ $150.00High
i
10/27/2020BarclaysBoost Price TargetOverweight$140.00 ➝ $150.00High
i
10/9/2020CSFBBoost Price TargetOutperform$143.00 ➝ $158.00Medium
i
10/9/2020Credit Suisse GroupBoost Price TargetOutperform$143.00 ➝ $158.00High
i
9/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$161.00 ➝ $143.00High
i
9/16/2020TruistBoost Price TargetBuy$150.00 ➝ $165.00Low
i
7/24/2020JPMorgan Chase & Co.Boost Price TargetOverweight$142.00 ➝ $161.00Low
i
7/23/2020OppenheimerBoost Price Target$135.00 ➝ $140.00High
i
7/23/2020Deutsche Bank AktiengesellschaftBoost Price Target$132.00 ➝ $150.00Medium
i
7/23/2020Piper SandlerBoost Price TargetNeutral$132.00 ➝ $138.00Low
i
7/23/2020Raymond JamesBoost Price TargetCautious ➝ Outperform$130.00 ➝ $140.00High
i
7/23/2020SunTrust BanksBoost Price TargetBuy$130.00 ➝ $150.00High
i
7/23/2020MizuhoBoost Price TargetBuy$136.00 ➝ $145.00High
i
7/23/2020CitigroupBoost Price TargetBuy$131.00 ➝ $142.00High
i
7/13/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$121.00 ➝ $100.00Low
i
6/11/2020UBS GroupLower Price TargetBuy$138.00 ➝ $137.00High
i
5/29/2020MizuhoLower Price TargetBuy$150.00 ➝ $136.00High
i
5/20/2020CitigroupLower Price TargetBuy$168.00 ➝ $131.00Medium
i
4/27/2020UBS GroupLower Price TargetBuy$183.00 ➝ $138.00Low
i
4/22/2020SunTrust BanksLower Price TargetBuy$160.00 ➝ $140.00Medium
i
4/22/2020BarclaysBoost Price TargetOverweight$117.00 ➝ $127.00Medium
i
4/22/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$165.00 ➝ $132.00Medium
i
4/22/2020OppenheimerLower Price TargetOutperform$160.00 ➝ $135.00Medium
i
4/20/2020Raymond JamesLower Price TargetOutperform$165.00 ➝ $130.00High
i
4/13/2020SunTrust BanksLower Price TargetBuy$185.00 ➝ $160.00High
i
3/25/2020BarclaysReiterated RatingBuy$117.00High
i
3/19/2020Credit Suisse GroupReiterated RatingBuy$173.00Low
i
2/3/2020BarclaysBoost Price TargetOverweight ➝ Positive$172.00 ➝ $177.00Low
i
1/29/2020SunTrust BanksReiterated RatingBuy$185.00Medium
i
1/29/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $180.00Low
i
1/29/2020Credit Suisse GroupBoost Price TargetOutperform$169.00 ➝ $173.00Low
i
1/29/2020StephensBoost Price TargetOverweight$175.00 ➝ $180.00Medium
i
Rating by Scott Fidel at Stephens
1/29/2020CitigroupBoost Price TargetBuy$156.00 ➝ $168.00Medium
i
1/29/2020Royal Bank of CanadaBoost Price TargetOutperform$170.00 ➝ $173.00Medium
i
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$165.00High
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00Low
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$157.00 ➝ $186.00Low
i
12/6/2019Bank of AmericaUpgradeNeutral ➝ BuyHigh
i
Rating by Kevin Fischbeck at Bank of America Co.
10/30/2019BarclaysBoost Price TargetOverweight$145.00 ➝ $155.00Low
i
9/6/2019Bank of AmericaUpgradeUnderperform ➝ Neutral$130.00 ➝ $137.00Medium
i
8/7/2019StephensSet Price TargetBuy$150.00Low
i
Rating by Scott Fidel at Stephens
7/31/2019MizuhoSet Price TargetBuy$153.00N/A
i
Rating by Ann Hynes at Mizuho
7/10/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$147.00 ➝ $160.00Low
i
6/24/2019UBS GroupBoost Price TargetBuy$172.00 ➝ $181.00Medium
i
5/1/2019UBS GroupBoost Price TargetBuy ➝ Buy$164.00 ➝ $172.00Low
i
5/1/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$160.00 ➝ $165.00Medium
i
4/23/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$115.00 ➝ $135.00High
i
4/17/2019Jefferies Financial GroupSet Price TargetBuy$158.00High
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$155.00 ➝ $145.00Low
i
1/30/2019OppenheimerBoost Price TargetOutperform$142.00 ➝ $150.00Low
i
1/30/2019SunTrust BanksBoost Price TargetBuy$175.00Low
i
1/30/2019SVB LeerinkBoost Price TargetOutperform$160.00 ➝ $175.00Low
i
1/14/2019StephensInitiated CoverageOverweight$143.00Low
i
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$140.00Medium
i
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$162.00Medium
i
11/6/2018ArgusBoost Price TargetBuy ➝ Buy$150.00 ➝ $155.00Low
i
11/1/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$156.00 ➝ $165.00Low
i
10/31/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$155.00 ➝ $158.00Low
i
10/11/2018CitigroupBoost Price TargetBuy$136.00 ➝ $156.00Medium
i
9/21/2018Jefferies Financial GroupBoost Price TargetBuy$155.00Low
i
9/20/2018Robert W. BairdBoost Price TargetOutperform ➝ Positive$130.00 ➝ $150.00Low
i
9/18/2018Bank of AmericaBoost Price TargetUnderperform$125.00 ➝ $135.00Medium
i
9/10/2018Royal Bank of CanadaBoost Price TargetOutperform$150.00Low
i
9/7/2018ArgusBoost Price TargetBuy$150.00Low
i
9/5/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$115.00 ➝ $124.00Low
i
9/5/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$145.00 ➝ $155.00Low
i
9/4/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$150.00High
i
9/4/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $150.00Low
i
9/4/2018MizuhoSet Price TargetBuy$150.00Low
i
Rating by Ann Hynes at Mizuho
8/16/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$105.00 ➝ $115.00Medium
i
8/14/2018BarclaysInitiated CoverageOverweight$150.00Low
i
8/2/2018MizuhoReiterated RatingBuy$145.00Low
i
Rating by Ann Hynes at Mizuho
7/30/2018JPMorgan Chase & Co.Boost Price TargetOverweight$151.00Low
i
7/27/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$122.00 ➝ $143.00Low
i
7/26/2018Piper Jaffray CompaniesReiterated RatingHold$124.00Low
i
7/26/2018Jefferies Financial GroupReiterated RatingBuy$135.00Medium
i
7/26/2018SunTrust BanksBoost Price TargetBuy$145.00High
i
7/26/2018SVB LeerinkBoost Price TargetOutperform$125.00 ➝ $140.00High
i
7/20/2018Cantor FitzgeraldReiterated RatingBuy$115.00Low
i
7/20/2018SunTrust BanksReiterated RatingBuy$125.00Low
i
7/13/2018Morgan StanleyBoost Price TargetUnderweight$91.00 ➝ $98.00Low
i
3/23/2018MizuhoInitiated CoverageBuy$115.00Medium
i
Rating by Sheryl Skolnick at Mizuho
2/12/2018ArgusBoost Price TargetPositive ➝ Buy$9.26 ➝ $114.00Low
i
Rating by Jasper Hellweg at Argus
2/1/2018Sanford C. BernsteinReiterated RatingMarket Perform$105.00 ➝ $116.00Low
i
2/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $115.00Low
i
2/1/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$84.00 ➝ $91.00Low
i
1/31/2018Royal Bank of CanadaBoost Price TargetOutperform$117.00Low
i
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$115.00 ➝ $122.00Low
i
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $120.00Low
i
1/31/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$120.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
1/30/2018Piper Jaffray CompaniesReiterated RatingHold$101.00Low
i
1/30/2018Cantor FitzgeraldReiterated RatingBuy$115.00High
i
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$116.00High
i
1/24/2018William BlairReiterated RatingHoldMedium
i
Rating by M. Larew at William Blair
1/12/2018Robert W. BairdSet Price TargetBuy$104.00Medium
i
Rating by Whit Mayo at Robert W. Baird
1/10/2018ArgusSet Price TargetBuy$97.00Low
i
1/4/2018Bank of AmericaDowngradeNeutral ➝ Underperform$94.00 ➝ $90.00Medium
i
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ NeutralHigh
i
1/3/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$81.00High
i
12/26/2017Credit Suisse GroupReiterated RatingOutperform$25.00Low
i
12/21/2017SunTrust BanksSet Price TargetBuy$105.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$85.00High
i
12/12/2017CitigroupUpgradeNeutral ➝ BuyMedium
i
11/30/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightHigh
i
11/21/2017William BlairReiterated RatingMarket PerformN/A
i
Rating by M. Larew at William Blair
11/6/2017CitigroupLower Price TargetNeutral ➝ Neutral$87.00 ➝ $81.00N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$95.00N/A
i
11/1/2017Jefferies Financial GroupLower Price TargetBuy$90.00 ➝ $88.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
11/1/2017MizuhoLower Price TargetBuy$85.00 ➝ $84.00N/A
i
Rating by Sheryl Skolnick at Mizuho
11/1/2017Piper Jaffray CompaniesReiterated RatingBuy$82.00N/A
i
10/31/2017Cantor FitzgeraldReiterated RatingBuy$90.00N/A
i
10/20/2017MizuhoReiterated RatingBuyN/A
i
Rating by Sheryl Skolnick at Mizuho
10/19/2017Robert W. BairdSet Price TargetBuy$93.00 ➝ $86.00N/A
i
10/19/2017OppenheimerReiterated RatingBuy$95.00 ➝ $90.00N/A
i
10/19/2017Bank of AmericaLower Price TargetNeutral$92.00 ➝ $86.00N/A
i
10/19/2017Royal Bank of CanadaReiterated RatingOutperform$90.00N/A
i
10/19/2017KeyCorpReiterated RatingOverweight$95.00 ➝ $90.00N/A
i
10/19/2017Jefferies Financial GroupReiterated RatingBuy$90.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/18/2017Raymond JamesDowngradeStrong-Buy ➝ Market PerformN/A
i
10/18/2017UBS GroupDowngradeOutperform ➝ Market PerformN/A
i
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$90.00N/A
i
10/15/2017SunTrust BanksSet Price TargetBuy$90.00N/A
i
10/13/2017Cantor FitzgeraldReiterated RatingBuy$95.00N/A
i
10/13/2017Jefferies Financial GroupReiterated RatingBuy$92.00N/A
i
10/4/2017MizuhoReiterated RatingBuy$92.00N/A
i
10/4/2017Piper Jaffray CompaniesReiterated RatingBuy$92.00High
i
9/28/2017Robert W. BairdReiterated RatingBuyLow
i
9/7/2017KeyCorpReiterated RatingBuy$95.00Low
i
9/6/2017Cantor FitzgeraldReiterated RatingBuy$95.00Low
i
8/22/2017Robert W. BairdLower Price TargetOutperform$95.00 ➝ $93.00Low
i
8/17/2017Morgan StanleyLower Price TargetEqual Weight$88.00 ➝ $85.00Low
i
8/14/2017ArgusLower Price TargetBuy$100.00 ➝ $93.00Low
i
7/26/2017CitigroupLower Price TargetNeutral$89.00 ➝ $87.00Medium
i
7/26/2017Morgan StanleyReiterated RatingEqual Weight$90.00 ➝ $88.00Low
i
7/26/2017Bank of AmericaDowngradeBuy ➝ Neutral$102.00 ➝ $92.00Medium
i
6/28/2017ArgusInitiated CoverageBuy ➝ Buy$100.00Low
i
6/6/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$92.00 ➝ $100.00Low
i
Rating by A. Gupte at SVB Leerink LLC
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$90.00Low
i
4/17/2017Cantor FitzgeraldReiterated RatingBuy$95.00High
i
4/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$103.00Low
i
3/27/2017MizuhoUpgradeNeutral ➝ Buy$98.00High
i
2/1/2017Royal Bank of CanadaReiterated RatingOutperform$95.00 ➝ $98.00N/A
i
2/1/2017Royal Bank of CanadaBoost Price TargetOutperform$95.00 ➝ $98.00N/A
i
1/31/2017Evercore ISIBoost Price TargetBuy$88.00N/A
i
1/17/2017Avondale PartnersUpgradeMarket Perform ➝ Outperform$96.00N/A
i
Rating by P. Torch at Avondale Partners
1/4/2017Piper Jaffray CompaniesInitiated CoverageOverweight$81.00N/A
i
11/15/2016Sanford C. BernsteinReiterated RatingMarket Perform$89.00 ➝ $85.00N/A
i
11/9/2016Avondale PartnersDowngradeOutperform ➝ Market PerformN/A
i
Rating by P. Torch at Avondale Partners
11/9/2016MizuhoDowngradeBuy ➝ NeutralN/A
i
10/28/2016Royal Bank of CanadaReiterated RatingOutperform$88.00 ➝ $95.00N/A
i
10/28/2016Royal Bank of CanadaBoost Price TargetOutperform$88.00 ➝ $95.00N/A
i
Rating by Frank Morgan at Royal Bank of Canada
10/25/2016Wolfe ResearchInitiated CoverageOutperformN/A
i
10/13/2016KeyCorpUpgradeSector Weight ➝ Overweight$94.00N/A
i
9/22/2016Evercore ISIInitiated CoverageHold$89.00N/A
i
9/6/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
8/26/2016Jefferies Financial GroupReiterated RatingBuy$94.00N/A
i
8/10/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
7/29/2016Credit Suisse GroupReiterated RatingBuy$87.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
7/29/2016CitigroupLower Price TargetNeutral$86.00 ➝ $85.00N/A
i
7/29/2016MizuhoReiterated RatingBuy$102.00 ➝ $97.00N/A
i
Rating by Sheryl Skolnick at Mizuho
7/29/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$85.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
7/14/2016MizuhoReiterated RatingBuy$102.00N/A
i
Rating by Sheryl Skolnick at Mizuho
6/28/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/16/2016Sanford C. BernsteinInitiated CoverageMarket Perform$88.00N/A
i
6/1/2016Longbow ResearchDowngradeOutperform ➝ Market Perform$74.00N/A
i
6/1/2016SVB LeerinkDowngradeOutperform ➝ Mkt PerformN/A
i
6/1/2016BarclaysLower Price TargetOverweight$80.00 ➝ $79.00N/A
i
5/16/2016Sterne Agee CRTReiterated RatingBuyN/A
i
Rating by B. Wright at Sterne Agee CRT
5/16/2016Robert W. BairdReiterated RatingBuyN/A
i
5/5/2016Credit Suisse GroupReiterated RatingBuy$90.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
5/5/2016JPMorgan Chase & Co.Reiterated RatingBuy$85.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
5/5/2016Jefferies Financial GroupReiterated RatingBuy$94.00N/A
i
5/4/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
5/4/2016Bank of AmericaReiterated RatingBuy$92.00N/A
i
Rating by Kevin Fischbeck at Bank of America Co.
5/4/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
5/4/2016WedbushReiterated RatingOutperform$88.00 ➝ $90.00N/A
i
Rating by Sarah James at Wedbush
5/4/2016Royal Bank of CanadaReiterated RatingOutperform$86.00 ➝ $89.00N/A
i
4/17/2016Avondale PartnersReiterated RatingBuyN/A
i
Rating by Paula Torch at Avondale Partners
4/15/2016Avondale PartnersBoost Price TargetMarket Outperform$85.00 ➝ $92.00N/A
i
3/24/2016Credit Suisse GroupBoost Price TargetOutperform$78.00 ➝ $83.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
3/19/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
3/14/2016JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$76.00 ➝ $85.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
2/1/2016MizuhoBoost Price TargetBuy$80.00 ➝ $102.00N/A
i
Rating by Sheryl Skolnick at Mizuho
1/31/2016Cantor FitzgeraldReiterated RatingBuy$95.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
1/29/2016Credit Suisse GroupBoost Price Target$75.00 ➝ $78.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
1/29/2016Royal Bank of CanadaLower Price TargetOutperform$90.00 ➝ $86.00N/A
i
Rating by Frank Morgan at Royal Bank of Canada
1/28/2016WedbushReiterated RatingBuy$80.00N/A
i
1/21/2016UBS GroupBoost Price Target$88.00 ➝ $90.00N/A
i
Rating by A.J. Rice at UBS Group AG
1/19/2016OppenheimerLower Price Target$100.00 ➝ $85.00N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
1/11/2016OppenheimerReiterated RatingOutperform$100.00N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
1/6/2016BarclaysLower Price TargetOverweight$80.00 ➝ $79.00N/A
i
Rating by Joshua Raskin at Barclays PLC
1/6/2016Longbow ResearchDowngradeOutperform ➝ Market Perform$74.00N/A
i
1/6/2016Raymond JamesUpgradeMarket Perform ➝ Outperform$95.00N/A
i
1/6/2016SVB LeerinkDowngradeOutperform ➝ Market Perform$79.00 ➝ $74.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
1/4/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
i
12/17/2015Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
12/17/2015The Goldman Sachs GroupDowngradeBuy ➝ Neutral$80.00N/A
i
12/16/2015Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$75.00N/A
i
(Data available from 11/27/2015 forward)
HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2019, it operated 184 hospitals and 123 freestanding surgery centers located in 21 states and England. HCA Healthcare Inc. has collaboration with Truli to give small and medium-size employers a new option for funding health care coverage in Florida markets. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $153.40
$152.90
$154.99

50 Day Range

MA: $138.85
$123.94
$155.06

52 Week Range

Now: $153.40
$58.38
$155.84

Volume

35,571 shs

Average Volume

2,318,085 shs

Market Capitalization

$51.91 billion

P/E Ratio

15.51

Dividend Yield

N/A

Beta

1.54